Malaria Infections and Infestations Unspecified malaria
Conditions
Interventions
Text message reminder arm: Daily text messages reminding providers of national guidelines for treatment of malaria with artemether-lumefantrine (AL) have been developed based on training materials use
Sponsors
London School of Hygiene and Tropical Medicine (UK)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Male and female patients of all ages attending health facilities and drug stores during the week of the study will be eligible for inclusion (i.e. follow-up visit) if they are seeking treatment for fever or malaria for themselves or on behalf of someone else, and they are dispensed AL (health facilities) or purchase AL (drug shops).
Exclusion criteria
Exclusion criteria: Patients will be excluded from follow-up if they reside further than 10 km away from the drug outlet or if another family member was previously followed-up and interviewed by the study team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient adherence to AL is the primary outcome indicator and will be reported in two ways: 1. Patient took all expected doses of AL in three to four days 2. Patient took all expected doses of AL at six time points at different times of day between three and four times of day | — |
Secondary
| Measure | Time frame |
|---|---|
| Score of dispenser knowledge of advice to provide when dispensing AL (from dispenser interviews) | — |
Countries
Tanzania
Outcome results
None listed